Julphar 9M revenues stable at $340mln zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.
Gulf Pharmaceutical Industries (Julphar), amid the current political headwinds and currency devaluation in Egypt, posted stable revenue of AED1.25 billion ($340 million) at constant currency in the first nine months (9M) of 2023.
Gulf Pharmaceutical Industries (Julphar), has seen EBITDA from continuing operations reaching AED45.4 million ($12.36 million) in Q1 2023 boosted by a 8.5% increase in revenue to AED454.1 million.